Wells Fargo’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-447,981
| Closed | -$8.13M | – | 7044 |
|
|
2020
Q3 | $8.13M | Buy |
447,981
+386,038
| +623% | +$7M | ﹤0.01% | 2036 |
|
|
2020
Q2 | $849K | Buy |
61,943
+26,705
| +76% | +$366K | ﹤0.01% | 3839 |
|
|
2020
Q1 | $504K | Sell |
35,238
-13,836
| -28% | -$198K | ﹤0.01% | 3911 |
|
|
2019
Q4 | $830K | Buy |
49,074
+23,504
| +92% | +$398K | ﹤0.01% | 3919 |
|
|
2019
Q3 | $393K | Sell |
25,570
-14,013
| -35% | -$215K | ﹤0.01% | 4415 |
|
|
2019
Q2 | $929K | Buy |
39,583
+4,789
| +14% | +$112K | ﹤0.01% | 3848 |
|
|
2019
Q1 | $986K | Buy |
34,794
+21,518
| +162% | +$610K | ﹤0.01% | 3851 |
|
|
2018
Q4 | $400K | Sell |
13,276
-13,628
| -51% | -$411K | ﹤0.01% | 4339 |
|
|
2018
Q3 | $942K | Sell |
26,904
-7,148
| -21% | -$250K | ﹤0.01% | 3945 |
|
|
2018
Q2 | $807K | Buy |
34,052
+10,187
| +43% | +$241K | ﹤0.01% | 4062 |
|
|
2018
Q1 | $611K | Sell |
23,865
-8,531
| -26% | -$218K | ﹤0.01% | 4160 |
|
|
2017
Q4 | $563K | Buy |
32,396
+24,389
| +305% | +$424K | ﹤0.01% | 4213 |
|
|
2017
Q3 | $222K | Buy |
+8,007
| New | +$222K | ﹤0.01% | 4702 |
|